"Medidata is at the forefront of a critical shift in the life sciences sector," said Anthony Costello, CEO, Medidata. "By harnessing AI-powered solutions and partnering with visionaries, we aren't ...

To be able to identify the different types of headaches and know when to be alarmed and see a doctor, HI-Eisai Pharmaceutical ... doubling of vision, paralysis, and increase in sleeping time ...

Biogen and Eisai have already filed for approval of their ... condition that can cause problems with balance, movement, vision, speech and swallowing that also features a build-up of toxic tau ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

After hours: February 3 at 4:10:51 PM EST Loading Chart for EYE ...

4307.T Nomura Research Institute, Ltd.